Literature DB >> 26830696

Quantification of respiration-induced esophageal tumor motion using fiducial markers and four-dimensional computed tomography.

Peng Jin1, Maarten C C M Hulshof2, Rianne de Jong2, Jeanin E van Hooft3, Arjan Bel2, Tanja Alderliesten2.   

Abstract

BACKGROUND AND
PURPOSE: Respiration-induced tumor motion is an important geometrical uncertainty in esophageal cancer radiation therapy. The aim of this study was to quantify this motion using fiducial markers and four-dimensional computed tomography (4DCT).
MATERIALS AND METHODS: Twenty esophageal cancer patients underwent endoscopy-guided marker implantation in the tumor volume and 4DCT acquisition. The 4DCT data were sorted into 10 breathing phases and the end-of-inhalation phase was selected as reference. We quantified for each visible marker (n=60) the motion in each phase and derived the peak-to-peak motion magnitude throughout the breathing cycle. The motion was quantified and analyzed for four different regions and in three orthogonal directions.
RESULTS: The median(interquartile range) of the peak-to-peak magnitudes of the respiration-induced marker motion (left-right/anterior-posterior/cranial-caudal) was 1.5(0.5)/1.6(0.5)/2.9(1.4) mm for the proximal esophagus (n=6), 1.5(1.4)/1.4(1.3)/3.7(2.6) mm for the middle esophagus (n=12), 2.6(1.3)/3.3(1.8)/5.4(2.9) mm for the distal esophagus (n=25), and 3.7(2.1)/5.3(1.8)/8.2(3.1) mm for the proximal stomach (n=17).
CONCLUSIONS: The variations in the results between the three directions, four regions, and patients suggest the need of individualized region-dependent anisotropic internal margins. Therefore, we recommend using markers with 4DCT to patient-specifically adapt the internal target volume (ITV). Without 4DCT, 3DCTs at the end-of-inhalation and end-of-exhalation phases could be alternatively applied for ITV individualization.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  4DCT; Esophageal cancer; Fiducial marker; Radiation therapy; Respiration-induced motion

Mesh:

Year:  2016        PMID: 26830696     DOI: 10.1016/j.radonc.2016.01.005

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  A Novel Absorbable Radiopaque Hydrogel Spacer to Separate the Head of the Pancreas and Duodenum in Radiation Therapy for Pancreatic Cancer.

Authors:  Avani D Rao; Ziwei Feng; Eun Ji Shin; Jin He; Kevin M Waters; Stephanie Coquia; Robert DeJong; Lauren M Rosati; Lin Su; Dengwang Li; Juan Jackson; Stephen Clark; Jeffrey Schultz; Danielle Hutchings; Seong-Hun Kim; Ralph H Hruban; Theodore L DeWeese; John Wong; Amol Narang; Joseph M Herman; Kai Ding
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-08-14       Impact factor: 7.038

2.  Feasibility of Using Hydrogel Spacers for Borderline-Resectable and Locally Advanced Pancreatic Tumors.

Authors:  Tossapol Kerdsirichairat; Amol K Narang; Elizabeth Thompson; Seong-Hun Kim; Avani Rao; Kai Ding; Eun Ji Shin
Journal:  Gastroenterology       Date:  2019-07-12       Impact factor: 22.682

3.  Tailoring four-dimensional cone-beam CT acquisition settings for fiducial marker-based image guidance in radiation therapy.

Authors:  Peng Jin; Niek van Wieringen; Maarten C C M Hulshof; Arjan Bel; Tanja Alderliesten
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-12

4.  Esophageal motion characteristics in thoracic esophageal cancer: Impact of clinical stage T4 versus stages T1-T3.

Authors:  Yuta Kobayashi; Miyako Myojin; Shinichi Shimizu; Masao Hosokawa
Journal:  Adv Radiat Oncol       Date:  2016-08-23

5.  Fiducial markers coupled with 3D PET/CT offer more accurate radiation treatment delivery for locally advanced esophageal cancer.

Authors:  Jasmine A Oliver; Puja Venkat; Jessica M Frakes; Jason Klapman; Cynthia Harris; Jaime Montilla-Soler; Gautamy C Dhadham; Baderaldeen A Altazi; Geoffrey G Zhang; Eduardo G Moros; Ravi Shridhar; Sarah E Hoffe; Kujtim Latifi
Journal:  Endosc Int Open       Date:  2017-05-31

6.  Quantifying esophageal motion during free-breathing and breath-hold using fiducial markers in patients with early-stage esophageal cancer.

Authors:  Yoshiko Doi; Yuji Murakami; Nobuki Imano; Yuki Takeuchi; Ippei Takahashi; Ikuno Nishibuchi; Tomoki Kimura; Yasushi Nagata
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

7.  Demonstration of Safety and Feasibility of Hydrogel Marking of the Pancreas-Duodenum Interface for Image Guided Radiation Therapy (IGRT) in a Porcine Model: Implications in IGRT for Pancreatic Cancer Patients.

Authors:  Avani D Rao; Eun Ji Shin; Sarah E Beck; Caroline Garrett; Seong-Hun Kim; Nam Ju Lee; Eleni Liapi; John Wong; Joseph Herman; Amol Narang; Kai Ding
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-03-02       Impact factor: 7.038

8.  A study to investigate the influence of cardiac motion on the robustness of pencil beam scanning proton plans in oesophageal cancer.

Authors:  Melissa Thomas; Gilles Defraene; Mario Levis; Edmond Sterpin; Maarten Lambrecht; Umberto Ricardi; Karin Haustermans
Journal:  Phys Imaging Radiat Oncol       Date:  2020-10-13

9.  The Feasibility of Haar Feature-Based Endoscopic Ultrasound Probe Tracking for Implanting Hydrogel Spacer in Radiation Therapy for Pancreatic Cancer.

Authors:  Ziwei Feng; Hamed Hooshangnejad; Eun Ji Shin; Amol Narang; Muyinatu A Lediju Bell; Kai Ding
Journal:  Front Oncol       Date:  2021-11-04       Impact factor: 6.244

10.  Cone-Beam CT-based position verification for oesophageal cancer: Evaluation of registration methods and anatomical changes during radiotherapy.

Authors:  A van Nunen; M J C van der Sangen; M van Boxtel; P M A van Haaren
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2017-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.